BeiGene

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeiGene and other ETFs, options, and stocks.

About ONC

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations.

CEO

John V. Oyler

CEOJohn V. Oyler

Employees

11,000

Employees11,000

Headquarters

Basel, Basel-Landschaft (Basle Country)

HeadquartersBasel, Basel-Landschaft (Basle Country)

Founded

2010

Founded2010

Employees

11,000

Employees11,000

ONC Key Statistics

Market cap

37.78B

Market cap37.78B

Price-Earnings ratio

585.44

Price-Earnings ratio585.44

Dividend yield

—

Dividend yield—

Average volume

336.62K

Average volume336.62K

High today

$308.97

High today$308.97

Low today

$302.00

Low today$302.00

Open price

$305.82

Open price$305.82

Volume

222.24K

Volume222.24K

52 Week high

$385.22

52 Week high$385.22

52 Week low

$170.99

52 Week low$170.99

Stock Snapshot

As of today, BeiGene(ONC) shares are valued at $306.05. The company's market cap stands at 37.78B, with a P/E ratio of 585.44.

As of 2025-12-18, BeiGene(ONC) stock has fluctuated between $302.00 and $308.97. The current price stands at $306.05, placing the stock +1.3% above today's low and -0.9% off the high.

BeiGene(ONC) shares are trading with a volume of 222.24K, against a daily average of 336.62K.

During the past year, BeiGene(ONC) stock moved between $170.99 at its lowest and $385.22 at its peak.

Analyst ratings

97%

of 29 ratings

Buy

96.6%

Hold

3.4%

Sell